Market Value50,985,000
Total Holdings51
File Date2018-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
NKTR / Nektar Therapeutics
CLVS / Clovis Oncology Inc
MRK / Merck & Co., Inc.
JUNO / Juno Therapeutics, Inc.
LLY / Eli Lilly and Company Call
PGNX / Progenics Pharmaceuticals, Inc.
SNR / New Senior Investment Group Inc
TSRO / TESARO, Inc.
LOXO / Loxo Oncology, Inc.
SAGE / Sage Therapeutics, Inc. Put
CFRX / ContraFect Corp
PRTK / Paratek Pharmaceuticals Inc.
BIVV / Bioverativ Inc.
AVXS / AveXis, Inc.
PCRX / Pacira BioSciences, Inc.
MDCO / Medicines Company
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology Put
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
US0153511094 / Alexion Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
451731103 / Ignyta, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
PGEN / Precigen, Inc.
KPTI / Karyopharm Therapeutics Inc.
US0153511094 / Alexion Pharmaceuticals, Inc. Call
INCY / Incyte Corporation
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
HRTX / Heron Therapeutics, Inc.
AMGN / Amgen Inc.
SCYX / SCYNEXIS, Inc.
ADMS / Adamas Pharmaceuticals Inc
ALNY / Alnylam Pharmaceuticals, Inc.
PFE / Pfizer Inc.
AKBA / Akebia Therapeutics, Inc.
SGEN / Seagen Inc
BMY / Bristol-Myers Squibb Company Call
UTHR / United Therapeutics Corporation
FGEN / FibroGen, Inc.
ILMN / Illumina, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc. Call
ACAD / ACADIA Pharmaceuticals Inc.
BMRN / BioMarin Pharmaceutical Inc.
IBB / iShares Trust - iShares Biotechnology ETF
MTD / Mettler-Toledo International Inc.
CKPT / Checkpoint Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
PRQR / ProQR Therapeutics N.V.
REGN / Regeneron Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
IQV / IQVIA Holdings Inc.
CELG / Celgene Corp.
BIIB / Biogen Inc.
TECH / Bio-Techne Corporation
GILD / Gilead Sciences, Inc.
NBIX / Neurocrine Biosciences, Inc.
ALKS / Alkermes plc
REPH / Societal CDMO Inc
CRL / Charles River Laboratories International, Inc.
ICPT / Intercept Pharmaceuticals Inc
VRTX / Vertex Pharmaceuticals Incorporated
QGEN / Qiagen N.V.
BMY / Bristol-Myers Squibb Company